TD Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18M | Sell |
|
|||||
|
2025
Q1 | $38.9M | Sell |
|
|||||
|
2024
Q4 | $54.4M | Sell |
|
|||||
|
2024
Q3 | $72.2M | Sell |
|
|||||
|
2024
Q2 | $88.3M | Buy |
|
|||||
|
2024
Q1 | $79.2M | Sell |
|
|||||
|
2023
Q4 | $101M | Buy |
|
|||||
|
2023
Q3 | $72.2M | Buy |
|
|||||
|
2023
Q2 | $61.6M | Buy |
|
|||||
|
2023
Q1 | $43.3M | Sell |
|
|||||
|
2022
Q4 | $44.2M | Sell |
|
|||||
|
2022
Q3 | $43.5M | Buy |
|
|||||
|
2022
Q2 | $31.5M | Buy |
|
|||||
|
2022
Q1 | $30.8M | Sell |
|
|||||
|
2021
Q4 | $35.9M | Buy |
|
|||||
|
2021
Q3 | $41.6M | Buy |
|
|||||
|
2021
Q2 | $39.7M | Sell |
|
|||||
|
2021
Q1 | $37.2M | Buy |
|
|||||
|
2020
Q4 | $32M | Buy |
|
|||||
|
2020
Q3 | $32.3M | Buy |
|
|||||
|
2020
Q2 | $24.1M | Sell |
|
|||||
|
2020
Q1 | $39.6M | Buy |
|
|||||
|
2019
Q4 | $28.3M | Buy |
|
|||||
|
2019
Q3 | $19.6M | Sell |
|
|||||
|
2019
Q2 | $20.8M | Buy |
|
|||||
|
2019
Q1 | $20.7M | Sell |
|
|||||
|
2018
Q4 | $32.9M | Sell |
|
|||||
|
2018
Q3 | $39.9M | Sell |
|
|||||
|
2018
Q2 | $34.6M | Sell |
|
|||||
|
2018
Q1 | $42.9M | Sell |
|
|||||
|
2017
Q4 | $55.3M | Sell |
|
|||||
|
2017
Q3 | $58.5M | Buy |
|
|||||
|
2017
Q2 | $48.6M | Sell |
|
|||||
|
2017
Q1 | $51.9M | Sell |
|
|||||
|
2016
Q4 | $54.9M | Sell |
|
|||||
|
2016
Q3 | $64M | Buy |
|
|||||
|
2016
Q2 | $47.6M | Sell |
|
|||||
|
2016
Q1 | $53.4M | Sell |
|
|||||
|
2015
Q4 | $68.2M | Buy |
|
|||||
|
2015
Q3 | $61.5M | Sell |
|
|||||
|
2015
Q2 | $105M | Sell |
|
|||||
|
2015
Q1 | $114M | Sell |
|
|||||
|
2014
Q4 | $97.3M | Sell |
|
|||||
|
2014
Q3 | $96.8M | Buy |
|
|||||
|
2014
Q2 | $85.4M | Sell |
|
|||||
|
2014
Q1 | $85.4M | Buy |
|
|||||
|
2013
Q4 | $75.4M | Buy |
|
|||||
|
2013
Q3 | $62.6M | Sell |
|
|||||
|
2013
Q2 | $57M | Buy |
|